AzTrials
AzTrials

Opt OutNCT03351881

Evaluation of Attitudes Towards Organ Donation in Individualistic or Collectivistic Countries

A study testing Description of Organ Donation Policy in people with Opt Out and Opt In, run by Yale-NUS College at 1 site in Singapore.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

People make decisions every day, both for themselves and on behalf of others. In the case of organ donations, despite the opt-out systems used in Singapore where the default is a presumed consent on the part of the individual, the actualized donation rate is lower than expect. Read more about this study

Who is it for?
Ages 21 years and olderHealthy volunteers can take part
Conditions the study is for
Opt Out, Opt In, Opt Neutral
What is being tested?
Description of Organ Donation Policy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
600 participants
Where
1 siteSingapore
Study dates
Sep 2016to May 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Research participants should be above the age of 21, able to understand English fully, and have no active mental disorder or intellectual impairment.

Who cannot join

  • Below the age of 21, unable to understand English fully, or have active mental disorder or intellectual impairment.

Trial locations and contacts

1 site in 1 country.

Singapore1 site, 1 recruiting
  • Yale-NUS College

    Singapore, 138527

    Jean Liu, PhD, jeanliu@yale-nus.edu.sg

    Recruiting

Other trials in Singapore

About this study

Official title: Nudging Policies in Asia: Evaluating Singapore's Opt-out System for Organ Donation

People make decisions every day, both for themselves and on behalf of others. In the case of organ donations, despite the opt-out systems used in Singapore where the default is a presumed consent on the part of the individual, the actualized donation rate is lower than expect. This is partially because family members are called in to make surrogate decisions on behalf of the patient, especially patients near brain death or have been certified to be brain dead.

To address the shortfall in organ donations, the investigators plan to run three studies:

Read more
  • First, the investigators seek to conduct a representative survey of the public's perception towards organ donation. The investigators will focus on their views towards donating their own vs. family members' organs, and to explore the role of cultural influences on decision-making.
  • Second, the investigators will conduct the survey focusing on NUS students and the ways they respond to an opt-out, opt-in, or mandatory organ donation system.
  • Third, the investigators will conduct the survey on an online platform (MTurk) to gather the views of participants across India and USA about organ donation.

The studies have the potential to improve actualized organ donation rates, as well as to inform the medical community in their communication with family members.

Being tested
Description of Organ Donation Policy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Description of Organ Donation PolicyOther

    Participants will read about an organ donation policy type (opt-out, opt-in, or opt-neutral) and rate what they think or feel about it.

Study groups in NCT03351881
Study groupRoleWhat they receive
Opt OutActive comparatorNot described
Receives: Other: Description of Organ Donation Policy
Opt InActive comparatorNot described
Receives: Other: Description of Organ Donation Policy
Opt NeutralActive comparatorNot described
Receives: Other: Description of Organ Donation Policy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Decision to Donate Organ

    Likelihood of participants choosing to donate organs after brain death

    Measured: At the point of the survey, right after participants have read about the organ donation policy condition which they have been assigned.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Nov 2017
  2. Study startSep 2016
  3. Primary completionMay 2018 (estimated)
  4. Study completionMay 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
600 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03351881
Sponsor's protocol ID
HSS-1502-P02-02
Status last verified
Feb 2018
First submitted
17 Nov 2017
Last updated
12 Feb 2018
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Description of Organ Donation Policy in people with Opt Out and Opt In, run by Yale-NUS College at 1 site in Singapore.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 12 Feb 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Singapore. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Decision to Donate Organ (time frame: At the point of the survey, right after participants have read about the organ donation policy condition which they have been assigned.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Feb 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in